Live feed
Filing
SC 13D/A
SC 13D/A0000078003-22-000049·Allogene Therapeutics, Inc.
Schedule 13D ownership disclosure
Allogene Therapeutics Inc
Security class unavailable · CUSIP: 019770106
Event date: 2022-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 22,032,040
- Percent of class
- 15.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000078003-22-000049
- Form type
- SC 13D/A
- Filer
- Allogene Therapeutics, Inc.
- CIK
- CIK 1737287
- Filed
- Apr 07, 2022
- Reporting period
- Mar 31, 2022
- Description
- Schedule 13D beneficial ownership